Sign in

CIK 0000863894

  • Non-accelerated filer
  • Smaller reporting company
Ticker
VERU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
WI
Entity type
Operating
EIN
391144397
Phone
+1 312-595-9123
Business address
2916 N. MIAMI AVENUE, SUITE 1000, MIAMI, FL, 33127
Former names
FEMALE HEALTH CO
  1. 4 Open-market buy Director bought 3,000 shares at $1.47 ($4,410)
  2. 4 Open-market buy Director bought 3,500 shares at $1.47 ($5,145)
  3. 4 Open-market buy Director bought 3,000 shares at $1.43 ($4,290)
  4. 4 Open-market buy Director bought 3,500 shares at $1.47 ($5,145)
  5. 4 Open-market sale President and CEO sold 4,996 shares at $1.50 ($7,494)
  6. 4 Open-market buy Director bought 3,400 shares at $1.39 ($4,726)
  7. 4 Open-market buy Director bought 5,000 shares at $1.27 ($6,350)
  8. 4 Open-market buy Director bought 3,000 shares at $1.32 ($3,960)
  9. 4 Open-market buy Director bought 6,000 shares at $1.30 ($7,800)
  10. 4 Open-market buy Director bought 5,000 shares at $1.35 ($6,750)
  11. 4 Open-market buy Director bought 5,000 shares at $1.36 ($6,795)
  12. 4 Open-market sale President and CEO sold 4,650 shares at $1.52 ($7,085)
  13. 4 Open-market buy Director bought 13,681 shares at $1.36 ($18,654)
  14. 4 Open-market sale President and CEO sold 10,455 shares at an average $1.50 ($15,724)
  15. 4 Open-market sale President and CEO sold 4,400 shares at $1.33 ($5,859)
  16. 4 Open-market sale President and CEO sold 25,600 shares at an average $1.34 ($34,347)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market buy Director bought 30,000 shares at $1.42 ($42,672)
  20. 4 Open-market buy Chief Scientific Officer bought 100,000 shares at an average $1.46 ($146,160)

Page 8 of 30 · 594 filings